ABSTRACT Transferrin (Ti) is the iron-transport protein of vertebrate serum.
exons of similar size in the 5 and 3' regions of the genes. These observations strongly indicate that present-day transferrins arose by gene duplication, and it has been proposed that this family of genes evolved by a series of independent gene duplications from a common ancestor, this ancestor itself deriving from a primordial gene by internal duplication (5).
Tf is an important factor in cellular processes and seems to play complex physiological roles related to cell function, differentiation, and proliferation.
In this review, we will discuss different aspects of the regulation of the expression of the gene encoding this essential protein.
TRANSFERRIN EXPRESSION IN FETAL AND ADULT ORGANS
Tf is essentially synthesized in the fetal and adult liver. In the mouse embryo, the liver develops from the gut endoderm at around 9 days of development. However, whole embryos from 6 days after gestation have detectable levels of Tf mRNA ( However, we think that current experiments performed with transgenic mice may rapidly clarify the situation.
In the chicken oviduct, although steroid hormones strongly regulate Tf transcription (11), nutritional iron deficiency has no effect on the levels of Tf mRNA (24 (Fig. 1) (29) . The activity of the promoter drops to about -H515 15% when the PRI site is mutated and to 30% when the PRII site is mutated (E. Schaeffer, unpublished observations). Using the G-free cassette system in in vitro transcription assays, it was determined that the proteins interacting with PRI are transcriptional activators. Indeed, the PRI site, together with its own TATA box or with a canonical TATA box, is able to direct the transcription of the cassette in the presence of crude liver nuclear extracts ( Fig. 2) (33) . Thus, transient expression experiments have shown that PRI and PRII are both necessary to obtain high, hepatic-specific expression (Fig. 1) . In contrast, in in vitro transcription assays, the nuclear factor interacting with the PR! region is the only protein whose binding is needed to promote liver-specific transcription (Fig. 2) antisera directed against the liver-enriched HNF-3 family of factors.
In conclusion, the promoter and the enhancer activities of the Tf gene were analyzed in two systems, the hepatic and the Sertoli systems.
In the hepatic system, the Tf gene may use two liver-enriched transcriptional factors, C/EBPa and HNF-4 in the promoter, and in the enhancer, HNF-3a and others ubiquitous factors, in a Tf-specific combination. In Sertoli cells, where the enhancer is not active, the regulatory elements PR! and PR!! participate differently in the mechanisms governing cell type-specific expression, and the transcriptional factors interacting with the promoter are different from C/EBPa and HNF-4 (Fig. 4) . 
